Top 3 Healthcare Stocks That Could Save Your Portfolio This Month

Benzinga and Yahoo Finance LLC may earn commission or revenue for some articles through the links below.

The most oversold healthcare stocks represent an opportunity to buy undervalued companies.

RSI is a momentum indicator, which compares a stock’s strength on days when prices rise to strength on days when prices fall. Compared to a stock’s price action, it can give traders better insight into how a stock may perform in the short term. An asset is usually considered oversold when the RSI is below 30, according to Benzinga Pro.

Don’t miss:

• This multi-billion dollar fund invested in the next big real estate boom, here’s how you can sign up for $10.
  This is a paid advertisement. Please carefully consider the Fundrise Flagship Fund’s investment objectives, risks, fees and expenses before investing. This and other information can be found in fund prospectus. Read them carefully before investing.

• Your biggest profit may not come from the stock market. Invest like colleges, pension funds and the 1% do. Start investing in commercial real estate today.

Here is the latest list of major oversold players in this sector with an RSI near or below 30.

Nkarta Inc (NASDAQ:NKTX)

• On August 13, Nkarta reported better-than-expected EPS results for the second quarter. “Patients remain our focus, and the early execution of our clinical trials in disease areas is a testament to that commitment,” said Paul J. Hastings, CEO of Nkarta. “NKX019 has the potential to reach people living with a wide range of autoimmune diseases, and we will continue to evaluate ways to maximize our impact in this area. Our cell engineering allows us to evaluate a lymphodepleting regimen with reduced toxicity, limit hospitalization and patient burden, and spare the complications of other agents.” The company’s shares have fallen about 35% in the past month and are at a 52-week low of $1.32.

• RSI value: 29.34

• NKTX Price Action: Nkarta shares fell 2% to close at $3.84 on Monday.

• Benzinga Pro’s real-time news feed has been alerted to the latest NKTX news.

Moderna Inc (NASDAQ:MRNA)

• On Sept. 30, Moderna said it dosed the first U.S. participant in the phase 3 Nova 301 trial evaluating the efficacy, safety and immunogenicity of an experimental norovirus vaccine, mRNA-1403. “Norovirus is a significant public health problem that affects millions of people around the world each year, leading to severe symptoms and, in some cases, hospitalization,” said Stéphane Bancel, CEO of Moderna. “By advancing our experimental norovirus vaccine into a pivotal Phase 3 trial, we are one step closer to potentially providing a new tool to prevent infection with this highly contagious virus, which places a significant burden on healthcare systems globally.” The company’s shares have fallen about 23% in the past month. It has a 52-week low of $58.33.

• RSI value: 24.97

• MRNA Price Action: Moderna shares fell 2.5% to close at $58.72 on Monday.

• Benzinga Pro’s graphing tool helped identify the trend of the mRNA stock.

The story continues

AMN Healthcare Services, Inc. (NYSE:AMN)

• On October 7, B of A Securities analyst Kevin Fischbeck downgraded AMN Healthcare Services from Neutral to Underperform and lowered his price target from $65 to $48. Shares of the company are down about 15% in the past month and have a 52-week low of $36.50.

• RSI value: 29.20

• AMN Price Action: Shares of AMN Healthcare gained 0.8% to close at $38.64 on Monday.

• Benzinga Pro’s signals feature heralded a potential breakout in AMN stock.

Wondering if your investments can take you to a $5,000,000 nest egg? Talk to a financial advisor today. The free SmartAsset tool matches you with up to three verified financial advisors serving your area and you can interview at no cost. to decide which one is right for you.

Continue reading:

• Interest rates are falling, but you can still get great returns in real estate. Find out how.

• A billion dollar investment strategy with minimums as low as $10 — you can become part of the next big real estate boom today.
  This is a paid advertisement. Please carefully consider the Fundrise Flagship Fund’s investment objectives, risks, fees and expenses before investing. This and other information can be found in fund prospectus. Read them carefully before investing.

This article Top 3 Health Care Stocks That Could Save Your Portfolio This Month originally appeared on Benzinga.com